Screener
LifeStance Health Group LFST Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $435.35M+26.1% | $403.48M+21.2% | $382.2M+17.4% | $363.81M+16.3% | $345.31M+10.6% | ||
| $108.14M+11.1% | $100.33M+6.2% | $94.78M+1.1% | $95.62M+12.1% | $97.38M+2.3% | ||
| $404.7M+16.2% | $381.19M+15.0% | $364.11M+12.2% | $356.4M+14.0% | $348.26M+6.1% | ||
| $30.65M+1,139% | $22.28M+1,289% | $18.08M— | $7.41M+15,666% | -$2.95M+81.5% | ||
| 7%+7.9pp | 5.5%+5.0pp | 4.7%+4.7pp | 2%+2.0pp | -0.9%+4.3pp | ||
| $2.63M-9.2% | $1.79M-41.7% | $2.88M-69.4% | $2.81M-48.0% | $2.9M-50.2% | ||
| -$3.2M-6.8% | -$2.52M+17.9% | -$2.88M+71.0% | -$2.84M+47.7% | -$2.99M+55.2% | ||
| $27.46M+562% | $19.76M+1,444% | $15.2M+271% | $4.57M+185% | -$5.94M+73.7% | ||
| $3.85M+279% | $5.52M+353% | $3.54M+300% | $3.5M+508% | -$2.15M-428% | ||
| $23.61M+723% | $14.24M+1,909% | $11.67M+264% | $1.08M+51.9% | -$3.79M+83.7% | ||
| 5.4%+6.5pp | 3.5%+3.3pp | 3.1%+5.2pp | 0.3%+0.1pp | -1.1%+6.4pp | ||
| $44.9M+306% | $35.6M+132% | $31.52M+115% | $20.97M+38.3% | $11.06M+317% | ||
| 10.3%+7.1pp | 8.8%+4.2pp | 8.2%+3.7pp | 5.8%+0.9pp | 3.2%+2.4pp | ||
| $30.65M+1,139% | $22.28M+1,289% | $18.08M— | $7.41M+15,666% | -$2.95M+81.5% |
FAQ
- What is LifeStance Health Group's revenue?
- LifeStance Health Group (LFST) generated $1.6B in revenue over the trailing twelve months, up 20.4% year over year.
- Is LifeStance Health Group profitable?
- LifeStance Health Group reported $50.6M in net income over the trailing twelve months, a 3.2% net margin.
- What is LifeStance Health Group's earnings per share?
- LifeStance Health Group's diluted EPS over the trailing twelve months is $0.13.
- Where does LifeStance Health Group's income statement data come from?
- Every line is extracted from LifeStance Health Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
